6.270
+0.490
+(8.48%)
As of 9:56:25 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
255,870
218,774
166,845
146,021
--
Cost of Revenue
52,879
55,237
44,207
3,028
--
Gross Profit
202,991
163,537
122,638
142,993
--
Operating Expense
466,131
469,087
531,114
544,980
364,551
Operating Income
-263,140
-305,550
-408,476
-401,987
-364,551
Net Non Operating Interest Income Expense
55,877
61,863
19,660
14,625
52,834
Pretax Income
-215,627
-210,593
-325,722
-412,417
-427,766
Net Income Common Stockholders
-215,627
-210,593
-325,722
-412,417
-427,766
Diluted NI Available to Com Stockholders
-215,627
-210,593
-325,722
-412,417
-427,766
Basic EPS
-0.23
-0.22
-0.35
-0.44
-0.46
Diluted EPS
-0.23
-0.22
-0.35
-0.44
-0.46
Basic Average Shares
962,733
959,899
936,502
935,486
929,749
Diluted Average Shares
962,733
959,899
936,502
935,486
929,749
Total Expenses
519,010
524,324
575,321
548,008
364,551
Net Income from Continuing & Discontinued Operation
-215,627
-210,593
-325,722
-412,417
-427,766
Normalized Income
-215,627
-210,593
-321,635
-423,412
-434,544
Interest Income
66,652
74,042
33,866
27,807
64,660
Interest Expense
10,775
12,179
14,206
13,182
11,826
Net Interest Income
55,877
61,863
19,660
14,625
52,834
EBIT
-204,852
-198,414
-311,516
-399,235
-415,940
EBITDA
-130,795
-129,296
-256,328
-358,133
-385,813
Reconciled Cost of Revenue
52,879
55,237
44,207
3,028
--
Reconciled Depreciation
74,057
69,118
55,188
41,102
30,127
Net Income from Continuing Operation Net Minority Interest
-215,627
-210,593
-325,722
-412,417
-427,766
Total Unusual Items Excluding Goodwill
--
--
-4,087
10,995
6,778
Total Unusual Items
--
--
-4,087
10,995
6,778
Normalized EBITDA
-130,795
-129,296
-252,241
-369,128
-392,591
12/31/2020 - 12/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6855.HK Ascentage Pharma Group International
36.700
+3.82%
2142.HK HBM Holdings Limited
6.670
+11.54%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
293.600
+10.54%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.480
+3.50%
078160.KQ MEDIPOST Co., Ltd.
7,970.00
+5.28%
6978.HK Immunotech Biopharm Ltd
3.810
+7.00%
9969.HK InnoCare Pharma Limited
8.410
+6.32%
2509.HK Qyuns Therapeutics Co., Ltd.
7.990
+1.15%
1530.HK 3SBIO
12.220
+8.33%
HBMHF HBM Holdings Limited
1.1000
+21.59%